Literature DB >> 21592278

When 'dueling technologies' are mistaken for progress.

Christopher J Logothetis1.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21592278      PMCID： PMC3922611          DOI： 10.1111/j.1464-410X.2011.10243.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  8 in total

1.  Robotic surgery: identifying the learning curve through objective measurement of skill.

Authors:  L Chang; R M Satava; C A Pellegrini; M N Sinanan
Journal:  Surg Endosc       Date:  2003-09-10       Impact factor: 4.584

2.  Prospective trial of cryosurgical ablation of the prostate: five-year results.

Authors:  B J Donnelly; J C Saliken; D S Ernst; N Ali-Ridha; P M A Brasher; J W Robinson; J C Rewcastle
Journal:  Urology       Date:  2002-10       Impact factor: 2.649

3.  Patterns of treatment of patients with prostate cancer initially managed with surveillance: results from The CaPSURE database. Cancer of the Prostate Strategic Urological Research Endeavor.

Authors:  T M Koppie; G D Grossfeld; D Miller; J Yu; D Stier; J M Broering; D Lubeck; J M Henning; S C Flanders; P R Carroll
Journal:  J Urol       Date:  2000-07       Impact factor: 7.450

Review 4.  The current and potential role of cryoablation as a primary therapy for localized prostate cancer.

Authors:  Aaron E Katz; John C Rewcastle
Journal:  Curr Oncol Rep       Date:  2003-05       Impact factor: 5.075

5.  Prostate carcinoma incidence and patient mortality: the effects of screening and early detection.

Authors:  O W Brawley
Journal:  Cancer       Date:  1997-11-01       Impact factor: 6.860

6.  Screening and prostate-cancer mortality in a randomized European study.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

7.  How potent is potent? Evaluation of sexual function and bother in men who report potency after treatment for prostate cancer: data from CaPSURE.

Authors:  Matthew R Cooperberg; Theresa M Koppie; Deborah P Lubeck; John Ye; Gary D Grossfeld; Shilpa S Mehta; Peter R Carroll
Journal:  Urology       Date:  2003-01       Impact factor: 2.649

8.  Phase I/II trial of high intensity focused ultrasound for the treatment of previously untreated localized prostate cancer.

Authors:  Michael O Koch; Thomas Gardner; Liang Cheng; Russell J Fedewa; Ralf Seip; Narendra T Sanghvi; Narendra T Sangvhi
Journal:  J Urol       Date:  2007-10-22       Impact factor: 7.450
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.